Since GFB needs PPARα to display neuroprotection in Tay-Sachs mice, in the absence of a basal level of PPARα, GFB may not exhibit optimal therapeutic efficacy in TSD patients. The gene discussed is PPARA; the disease is Tay-Sachs disease.